The clinical-stage biopharmaceutical company (NASDAQ:SNNA) enjoyed an incredible rally and skyrocketed by as much as 76% on Monday.
There was no material news with regards to the company that could have been a catalyst. It is perhaps more intriguing since on September 17 it had emerged that the company had filed for Chapter 11 bankruptcy. This was done in order to restructure the company. That being said, the recent rally makes things very interesting.
Source: 3 Penny Stocks To Buy or Sell In October?
There was no material news with regards to the company that could have been a catalyst. It is perhaps more intriguing since on September 17 it had emerged that the company had filed for Chapter 11 bankruptcy. This was done in order to restructure the company. That being said, the recent rally makes things very interesting.
Source: 3 Penny Stocks To Buy or Sell In October?